Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buccal, Intranasal or Intravenous Lorazepam for the Treatment of Acute Convulsions in Children in Blantyre, Malawi: a Randomized Trial

NCT00343096 is registered in ClinicalTrials.gov with Kamuzu University of Health Sciences as lead sponsor.

NCT NCT00343096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00343096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buccal, Intranasal or Intravenous Lorazepam for the Treatment of Acute Convulsions in Children in Blantyre, Malawi: a Randomized Trial
Lead sponsor
Kamuzu University of Health Sciences
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2006
Completion date
March 31, 2009
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

convulsions, status epilepticus